Mild til moderat nedsat nyrefunktion påvirkede ikke farmakokinetikken for fulvestrant i klinisk relevant omfang.
Renal impairment Mild to moderate impairment of renal function did not influence the pharmacokinetics of fulvestrant to any clinically relevant extent.